Medical Devices Industry Reports

Reports > Medical Devices > Selected Report

Global Spine Biologics Market Report for Period 2017 till 2023

Single User: $0
Multiple User: $0
Enterprise User: $0


Report Summary:

In this report, the global Spine Biologics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Spine Biologics for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Spine Biologics market competition by top manufacturers/players, with Spine Biologics sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Zimmer Holding
Depuy Synthes
Medtronic(U.S.)
Nuvasive
Stryker Corporation
Orthofix International
K2M
Exactech
Wright Medical Technology
Nutech
Arthrex
X-Spine Systems(Bacterin International Holdings)
DR PRP USA
Alphatec spine
Life Spine
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Bone Graft
Bine Graft Substitute
Platelet Rich Plasma
BMAC
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Spine Biologics for each application, including
Anterior Cervical Discectomy and Fusion
Posterior Lumbar Interbody Fusion

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents / Index:

Table of Contents

Global Spine Biologics Sales Market Report 2017
1 Spine Biologics Market Overview
1.1 Product Overview and Scope of Spine Biologics
1.2 Classification of Spine Biologics by Product Category
1.2.1 Global Spine Biologics Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Spine Biologics Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Bone Graft
1.2.4 Bine Graft Substitute
1.2.5 Platelet Rich Plasma
1.2.6 BMAC
1.3 Global Spine Biologics Market by Application/End Users
1.3.1 Global Spine Biologics Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Anterior Cervical Discectomy and Fusion
1.3.3 Posterior Lumbar Interbody Fusion
1.4 Global Spine Biologics Market by Region
1.4.1 Global Spine Biologics Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Spine Biologics Status and Prospect (2012-2022)
1.4.3 China Spine Biologics Status and Prospect (2012-2022)
1.4.4 Europe Spine Biologics Status and Prospect (2012-2022)
1.4.5 Japan Spine Biologics Status and Prospect (2012-2022)
1.4.6 Southeast Asia Spine Biologics Status and Prospect (2012-2022)
1.4.7 India Spine Biologics Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Spine Biologics (2012-2022)
1.5.1 Global Spine Biologics Sales and Growth Rate (2012-2022)
1.5.2 Global Spine Biologics Revenue and Growth Rate (2012-2022)

2 Global Spine Biologics Competition by Players/Suppliers, Type and Application
2.1 Global Spine Biologics Market Competition by Players/Suppliers
2.1.1 Global Spine Biologics Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Spine Biologics Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Spine Biologics (Volume and Value) by Type
2.2.1 Global Spine Biologics Sales and Market Share by Type (2012-2017)
2.2.2 Global Spine Biologics Revenue and Market Share by Type (2012-2017)
2.3 Global Spine Biologics (Volume and Value) by Region
2.3.1 Global Spine Biologics Sales and Market Share by Region (2012-2017)
2.3.2 Global Spine Biologics Revenue and Market Share by Region (2012-2017)
2.4 Global Spine Biologics (Volume) by Application

3 United States Spine Biologics (Volume, Value and Sales Price)
3.1 United States Spine Biologics Sales and Value (2012-2017)
3.1.1 United States Spine Biologics Sales and Growth Rate (2012-2017)
3.1.2 United States Spine Biologics Revenue and Growth Rate (2012-2017)
3.1.3 United States Spine Biologics Sales Price Trend (2012-2017)
3.2 United States Spine Biologics Sales Volume and Market Share by Players
3.3 United States Spine Biologics Sales Volume and Market Share by Type
3.4 United States Spine Biologics Sales Volume and Market Share by Application

4 China Spine Biologics (Volume, Value and Sales Price)
4.1 China Spine Biologics Sales and Value (2012-2017)
4.1.1 China Spine Biologics Sales and Growth Rate (2012-2017)
4.1.2 China Spine Biologics Revenue and Growth Rate (2012-2017)
4.1.3 China Spine Biologics Sales Price Trend (2012-2017)
4.2 China Spine Biologics Sales Volume and Market Share by Players
4.3 China Spine Biologics Sales Volume and Market Share by Type
4.4 China Spine Biologics Sales Volume and Market Share by Application

5 Europe Spine Biologics (Volume, Value and Sales Price)
5.1 Europe Spine Biologics Sales and Value (2012-2017)
5.1.1 Europe Spine Biologics Sales and Growth Rate (2012-2017)
5.1.2 Europe Spine Biologics Revenue and Growth Rate (2012-2017)
5.1.3 Europe Spine Biologics Sales Price Trend (2012-2017)
5.2 Europe Spine Biologics Sales Volume and Market Share by Players
5.3 Europe Spine Biologics Sales Volume and Market Share by Type
5.4 Europe Spine Biologics Sales Volume and Market Share by Application

6 Japan Spine Biologics (Volume, Value and Sales Price)
6.1 Japan Spine Biologics Sales and Value (2012-2017)
6.1.1 Japan Spine Biologics Sales and Growth Rate (2012-2017)
6.1.2 Japan Spine Biologics Revenue and Growth Rate (2012-2017)
6.1.3 Japan Spine Biologics Sales Price Trend (2012-2017)
6.2 Japan Spine Biologics Sales Volume and Market Share by Players
6.3 Japan Spine Biologics Sales Volume and Market Share by Type
6.4 Japan Spine Biologics Sales Volume and Market Share by Application

7 Southeast Asia Spine Biologics (Volume, Value and Sales Price)
7.1 Southeast Asia Spine Biologics Sales and Value (2012-2017)
7.1.1 Southeast Asia Spine Biologics Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Spine Biologics Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Spine Biologics Sales Price Trend (2012-2017)
7.2 Southeast Asia Spine Biologics Sales Volume and Market Share by Players
7.3 Southeast Asia Spine Biologics Sales Volume and Market Share by Type
7.4 Southeast Asia Spine Biologics Sales Volume and Market Share by Application

8 India Spine Biologics (Volume, Value and Sales Price)
8.1 India Spine Biologics Sales and Value (2012-2017)
8.1.1 India Spine Biologics Sales and Growth Rate (2012-2017)
8.1.2 India Spine Biologics Revenue and Growth Rate (2012-2017)
8.1.3 India Spine Biologics Sales Price Trend (2012-2017)
8.2 India Spine Biologics Sales Volume and Market Share by Players
8.3 India Spine Biologics Sales Volume and Market Share by Type
8.4 India Spine Biologics Sales Volume and Market Share by Application

9 Global Spine Biologics Players/Suppliers Profiles and Sales Data
9.1 Zimmer Holding
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Spine Biologics Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Zimmer Holding Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Depuy Synthes
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Spine Biologics Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Depuy Synthes Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Medtronic(U.S.)
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Spine Biologics Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Medtronic(U.S.) Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Nuvasive
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Spine Biologics Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Nuvasive Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Stryker Corporation
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Spine Biologics Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Stryker Corporation Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Orthofix International
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Spine Biologics Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Orthofix International Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 K2M
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Spine Biologics Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 K2M Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Exactech
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Spine Biologics Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Exactech Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Wright Medical Technology
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Spine Biologics Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Wright Medical Technology Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Nutech
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Spine Biologics Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Nutech Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Arthrex
9.12 X-Spine Systems(Bacterin International Holdings)
9.13 DR PRP USA
9.14 Alphatec spine
9.15 Life Spine

10 Spine Biologics Maufacturing Cost Analysis
10.1 Spine Biologics Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Spine Biologics
10.3 Manufacturing Process Analysis of Spine Biologics

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Spine Biologics Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Spine Biologics Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Spine Biologics Market Forecast (2017-2022)
14.1 Global Spine Biologics Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Spine Biologics Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Spine Biologics Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Spine Biologics Price and Trend Forecast (2017-2022)
14.2 Global Spine Biologics Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Spine Biologics Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Spine Biologics Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Spine Biologics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Spine Biologics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Spine Biologics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Spine Biologics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Spine Biologics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Spine Biologics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Spine Biologics Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Spine Biologics Sales Forecast by Type (2017-2022)
14.3.2 Global Spine Biologics Revenue Forecast by Type (2017-2022)
14.3.3 Global Spine Biologics Price Forecast by Type (2017-2022)
14.4 Global Spine Biologics Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer


Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 24 hours.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 37926

Category: 18

Published date: 2017-12-03 20:12:16

Number of Pages: 110

Publisher Name:

Over all Rating: 0 % (Average of Ratings provided by clients)